Denise Herpai

419 total citations
21 papers, 318 citations indexed

About

Denise Herpai is a scholar working on Immunology, Molecular Biology and Biotechnology. According to data from OpenAlex, Denise Herpai has authored 21 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Molecular Biology and 7 papers in Biotechnology. Recurrent topics in Denise Herpai's work include Cancer Research and Treatments (7 papers), Glioma Diagnosis and Treatment (5 papers) and Virus-based gene therapy research (4 papers). Denise Herpai is often cited by papers focused on Cancer Research and Treatments (7 papers), Glioma Diagnosis and Treatment (5 papers) and Virus-based gene therapy research (4 papers). Denise Herpai collaborates with scholars based in United States, China and Türkiye. Denise Herpai's co-authors include Waldemar Debinski, Ralph B. D’Agostino, Anirudh Sattiraju, Kiran Kumar Solingapuram Sai, Akiva Mintz, Frankis G. Almaguel, Sara Ferluga, Carla M. Lema Tomé, Stephen B. Tatter and Darpan N. Pandya and has published in prestigious journals such as Oncogene, Scientific Reports and Oncotarget.

In The Last Decade

Denise Herpai

20 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denise Herpai United States 10 146 74 73 65 60 21 318
Kathleen S. Ensbey Australia 12 251 1.7× 86 1.2× 72 1.0× 76 1.2× 138 2.3× 22 430
Emily J. Girard United States 11 249 1.7× 70 0.9× 66 0.9× 52 0.8× 64 1.1× 24 406
Thomas S. van Solinge Netherlands 10 206 1.4× 92 1.2× 136 1.9× 46 0.7× 40 0.7× 13 403
Diahnn Futalan United States 8 216 1.5× 128 1.7× 78 1.1× 142 2.2× 87 1.4× 11 439
Kok‐Siong Chen United States 12 211 1.4× 63 0.9× 66 0.9× 85 1.3× 109 1.8× 21 398
Michael Zorniak United States 8 190 1.3× 126 1.7× 95 1.3× 28 0.4× 135 2.3× 10 366
Zhenghou Zhang China 8 321 2.2× 40 0.5× 153 2.1× 37 0.6× 37 0.6× 9 441
Sophie Guelfi France 8 157 1.1× 74 1.0× 79 1.1× 59 0.9× 90 1.5× 10 317
Laura A. Genovesi Australia 12 287 2.0× 112 1.5× 111 1.5× 25 0.4× 59 1.0× 15 439
Joshua D. Frenster United States 8 128 0.9× 43 0.6× 28 0.4× 44 0.7× 74 1.2× 16 260

Countries citing papers authored by Denise Herpai

Since Specialization
Citations

This map shows the geographic impact of Denise Herpai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Herpai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Herpai more than expected).

Fields of papers citing papers by Denise Herpai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise Herpai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Herpai. The network helps show where Denise Herpai may publish in the future.

Co-authorship network of co-authors of Denise Herpai

This figure shows the co-authorship network connecting the top 25 collaborators of Denise Herpai. A scholar is included among the top collaborators of Denise Herpai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Herpai. Denise Herpai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Puckett, Shelby, Kai‐Long Zhang, Denise Herpai, et al.. (2021). Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells. Molecular Therapy — Oncolytics. 22. 232–244. 5 indexed citations
2.
Sanders, Stephanie, Denise Herpai, Analiz Rodriguez, et al.. (2021). The Presence and Potential Role of ALDH1A2 in the Glioblastoma Microenvironment. Cells. 10(9). 2485–2485. 11 indexed citations
3.
Renfrow, Jaclyn J., M. Soike, James L. W. West, et al.. (2020). Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor. Scientific Reports. 10(1). 15195–15195. 23 indexed citations
4.
Sharma, Puja, Denise Herpai, Ralph B. D’Agostino, et al.. (2020). Multireceptor targeting of glioblastoma. Neuro-Oncology Advances. 2(1). vdaa107–vdaa107. 10 indexed citations
5.
Sharma, Puja, et al.. (2020). Drug Conjugates for Targeting Eph Receptors in Glioblastoma. Pharmaceuticals. 13(4). 77–77. 10 indexed citations
6.
Rossmeisl, John H., Denise Herpai, Thomas E. Cecere, et al.. (2020). Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas. Neuro-Oncology. 23(3). 422–434. 28 indexed citations
7.
Rossmeisl, John H., Denise Herpai, Ralph B. D’Agostino, et al.. (2020). EXTH-34. PHASE I TRIAL OF CONVECTION-ENHANCED DELIVERY OF IL13RA2 AND EPHA2 RECEPTOR TARGETED CYTOTOXINS IN DOGS WITH SPONTANEOUS INTRACRANIAL GLIOMAS. Neuro-Oncology. 22(Supplement_2). ii94–ii94. 1 indexed citations
8.
Sharma, Puja, Denise Herpai, John H. Rossmeisl, Stephen B. Tatter, & Waldemar Debinski. (2019). EXTH-54. MULTIVALENT TARGETED PROTEINS FOR GLIOBLASTOMA TREATMENT. Neuro-Oncology. 21(Supplement_6). vi93–vi94. 1 indexed citations
9.
Sanders, Stephanie, Denise Herpai, Lance D. Miller, & Waldemar Debinski. (2019). TMIC-36. ALDH1A2 AS A NOVEL PUTATIVE MARKER OF MACROPHAGE DIFFERENTIATION IN GBM. Neuro-Oncology. 21(Supplement_6). vi255–vi255. 1 indexed citations
10.
Su, Weijun, Lixin Hong, Xin Xu, et al.. (2018). miR-30 disrupts senescence and promotes cancer by targeting both p16INK4A and DNA damage pathways. Oncogene. 37(42). 5618–5632. 43 indexed citations
11.
Sharma, Puja, Denise Herpai, John H. Rossmeisl, Stephen B. Tatter, & Waldemar Debinski. (2018). EXTH-29. MULTI-RECEPTOR TARGETING IN GBM. Neuro-Oncology. 20(suppl_6). vi91–vi91. 1 indexed citations
12.
Rossmeisl, John H., Denise Herpai, John L. Robertson, et al.. (2018). EXTH-43. EFFECTIVE TREATMENT OF CANINE SPONTANEOUS GLIOMAS WITH A CYTOTOXIC COCKTAIL TARGETING IL-13RA2 AND EphA2 RECEPTORS. Neuro-Oncology. 20(suppl_6). vi94–vi94. 2 indexed citations
13.
Sai, Kiran Kumar Solingapuram, Anirudh Sattiraju, Frankis G. Almaguel, et al.. (2017). Peptide-based PET imaging of the tumor restricted IL13RA2 biomarker. Oncotarget. 8(31). 50997–51007. 28 indexed citations
14.
Rossmeisl, John H., Denise Herpai, John L. Robertson, et al.. (2017). P08.12 Tolerability and initial efficacy of convection-enhanced delivery of combinatorial IL-13RA2 and EphA2 targeted cytotoxins to dogs with spontaneous intracranial malignant gliomas. Neuro-Oncology. 19(suppl_3). iii56–iii56. 3 indexed citations
15.
Renfrow, Jaclyn J., Roy E. Strowd, Yue Huang, et al.. (2017). P08.14 In situ detection of hypoxia inducible factor 2 alpha in malignant gliomas. Neuro-Oncology. 19(suppl_3). iii57–iii57. 2 indexed citations
16.
Sattiraju, Anirudh, Kiran Kumar Solingapuram Sai, Darpan N. Pandya, et al.. (2017). IL13RA2 targeted alpha particle therapy against glioblastomas. Oncotarget. 8(26). 42997–43007. 67 indexed citations
17.
Riley, Kathryn, Denise Herpai, Waldemar Debinski, et al.. (2016). Selection of a Novel Aptamer Against Vitronectin Using Capillary Electrophoresis and Next Generation Sequencing. Molecular Therapy — Nucleic Acids. 5(11). e386–e386. 32 indexed citations
18.
Sai, Kiran Kumar Solingapuram, Frankis Almaguel, Anirudh Sattiraju, et al.. (2016). Radiolabeling and initial biological evaluations of [64Cu]NOTA-Pep-1L for imaging Glioblastoma (GBM ). 57. 1100–1100. 2 indexed citations
19.
Ferluga, Sara, Carla M. Lema Tomé, Denise Herpai, Ralph B. D’Agostino, & Waldemar Debinski. (2016). Simultaneous targeting of Eph receptors in glioblastoma. Oncotarget. 7(37). 59860–59876. 46 indexed citations
20.
Herpai, Denise, Yue Huang, Darren F. Seals, et al.. (2015). TMIC-07ALDH1A2 IS A CANDIDATE BIOMARKER FOR M2-TYPE MACROPHAGES IN GLIOBLASTOMA. Neuro-Oncology. 17(suppl 5). v215.7–v215. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen S. Ensbey Breakdown of academic impact, for papers by Emily J. Girard Breakdown of academic impact, for papers by Thomas S. van Solinge Breakdown of academic impact, for papers by Diahnn Futalan Breakdown of academic impact, for papers by Kok‐Siong Chen Breakdown of academic impact, for papers by Michael Zorniak Breakdown of academic impact, for papers by Zhenghou Zhang Breakdown of academic impact, for papers by Sophie Guelfi Breakdown of academic impact, for papers by Laura A. Genovesi Breakdown of academic impact, for papers by Joshua D. Frenster
Rankless by CCL
2026